Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
UK-based Mestag Therapeutics was established in 2020 to develop new medicines for people affected by inflammatory disease and cancer, based on insights into disease-driving fibroblast subpopulations. Fibroblasts are a type of cell present in many different tissues in the body; recent data point to them as being important drivers of disease. Historically, fibroblasts were thought […]
Cardea Bio is developing biology-based transistors for linking biology directly up to computers. These transistors leverage graphene and are designed to replace optical static observations with interactive live-streams of multi-omics signal analysis, representing a new life science observation paradigm according to the company, where multi-omics data-streams will be the new norm instead of most of […]
aiGENE is a US-based company developing a rapid, inexpensive, universal, pan-cancer screening test using DNA methylation technology licenced from The University of Queensland, Australia in 2020. The company’s approach uses an electrode based meter that generates a digital readout based on the amount of cancer DNA in a person’s blood. The “aiElectrode” is selectively sensitive […]